December 25, 2014 – Stock Market News

While Pfizer has not made any direct mention of purchasing AstraZeneca, they had a lot of interest in the drug company’s projected earnings.  Further, there has been no express announcement that they will not be sniffing around to buy AstraZeneca in the coming months.  AstraZeneca, in the meantime, has high hopes for its projected earnings, estimating some $45 billion within the next 10 years.  Despite his confidence, Pfizer has yet to be convinced, downplaying the projection as foolishly optimistic.  Investors continue to speculate whether and when another bid might be offered.

Between threats and critiques, Sony has partially reversed its decision regarding ”The Interview.”  In the face of 100 TB (terabyte) of stolen data and possibly the single best unintentional advertisement a film could ever dream to have before its release, “The Interview” is, in the end, set to have a limited showing on December 25th.  The possible reason the Guardians of Peace decided to hack Sony in the first place, “The Interview” had previously been written off as a $100 million loss when its release was cancelled.  It has also been the topic of discussion on countless news feeds, blogs, and even a presidential address.  While returns will not likely cover the mess of lost business, closed doors, and angst experienced by the release of Sony’s private data, it could at least console Sony’s bottom line.

 

Trade Forex, Commodities, Stocks and more, trade CFDs on the Plus 500 CFD trading platform! *CFD Service. 80.6% lose money - Register a real money account here and get trading right away.